Problems › Should We Buy a Competitor? › Manufacturing
Acquisitions fail on integration far more often than on price, and the integration cost is the number least likely to have been estimated. This page works through it for manufacturers specifically — including an unedited excerpt from a real analysis of a manufacturer.
Acquisitions fail on integration far more often than on price, and the integration cost is the number least likely to have been estimated. Manufacturers carry a specific bind here — the $45M automation case depends on the very customer that causes the margin problem. Until that is priced, contribution per machine hour will keep moving for reasons nobody can attribute, and the debate about synergy realism will stay a matter of opinion.
The case for buying a competitor is usually built on revenue synergies, which are the least reliable category of benefit and the slowest to arrive. Cost synergies are more predictable, and the honest ones are usually smaller than the model assumes.
The number that decides most outcomes is integration cost — systems, people, customer disruption, and the management attention diverted from the existing business for a year or more. It is routinely omitted because it is hard to estimate and does not appear on either company's accounts.
The disciplined version asks what specifically you get that you could not build or buy more cheaply another way, and what the business looks like if none of the revenue synergies materialise.
These three together are the signature. One on its own usually points somewhere else.
✓ The rationale leans on cross-selling to each other's customers
✓ Integration is described but not costed
✓ The acquisition is partly motivated by the core business having stalled
The move that usually makes it worse. Underwriting the deal on revenue synergies, which typically arrive late, smaller than modelled, or not at all.
It is for you if you run or finance a manufacturer and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a manufacturer. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Kessler Industrial Components, a sample company profile used for testing rather than a customer — $310M revenue, three plants.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Zero-capex JV turns existing tooling into recurring aftermarket cash flow that de-risks the entire diversification sequence.
The leak it closes. Eliminates 25–30% dealer take-rate currently captured entirely by OEM captive aftermarket
The assumption it rests on. Partner dealer network maintains exclusive shelf space for 5 years — the engine put the probability at 0.75.
| Investment required | $0 capex; $1.3M one-time operating expense for engineering time and legal fees |
| Expected return | Infinite (zero capex) on $12M Year-3 EBITDA |
| Revenue, year 1 | $4.8M aftermarket revenue (8% penetration) |
| Revenue, year 2 | $9.6M (14% penetration) |
| Revenue, year 3 | $14.4M (22% penetration) |
| Exit criteria | Terminate JV if aftermarket revenue run-rate remains below $2.4M annualized by Month 12 or if OEM contractual IP challenges block >30% of target SKUs |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For manufacturers it works through contribution per machine hour, capacity utilisation, customer concentration and scrap, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Twice — once standalone, and once for what it is worth specifically to you. The gap between those is the most you can pay and still create value, and it is usually narrower than expected.
Cost, substantially. They are within your control and can be scheduled. Revenue synergies depend on customers behaving as modelled, which is the assumption most often wrong.
Integration consuming more management attention than anyone budgeted, so that both businesses underperform during the period the deal was supposed to be paying back.
Materially, yes. The $45M automation case depends on the very customer that causes the margin problem — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are contribution per machine hour, capacity utilisation, customer concentration, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on contribution per machine hour and capacity utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.